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The Department of Public Health’s (DPH) Prescription Drug Monitoring Program (PMP) serves as a repository of data for all prescription drugs dispensed 
statewide, including those prescriptions that are sought after for illicit and non-medical use and thus represent the highest potential for abuse (federal 
Schedules II – V, including certain narcotics, stimulants and sedatives). The PMP also enables prescribers and dispensers to access a patient’s 
prescription history and can be used as a clinical decision-making tool, allowing the provider to have a holistic view of the patient’s medications. 
 
When interpreting PMP county-level data, it is important to emphasize that increases or decreases in a single measure may not indicate an increase or 
decrease in prescription misuse or abuse. Put simply, use does not always equate to abuse. There are many factors that might explain an unusually high 
rate of prescribing in a given area. For instance, an area which contains a large number of residents in long-term care facilities may result a high rate of 
opioid prescribing. 
 
These datasets inform critical discussions about opioid prescribing, provide an important baseline to better inform future policy decisions and allow the 
state and stakeholders to more meaningfully measure whether policy initiatives are effective. 
 
Effective October 6, 2014, all hydrocodone combination drug (HCD) products (e.g., Vicodin) were reclassified from Schedule III to Schedule II.  This 
reclassification during the last quarter of 2014 makes comparisons over time difficult to interpret. Beginning with CY 2015 data, reports of Schedule II 
products will include all HCD prescriptions.  
 
Individuals with activity of concern "thresholds" for this report are based on a 3-month time period. MDPH also releases an annual county-level report 
that provides thresholds that are based on a 12-month time period. Although the numbers (or rates) generated may appear to be comparable, they 
represent different time periods and are NOT an apples-to-apples comparison. The results are only comparable when the thresholds (e.g., 4 different 
providers and 4 different pharmacies), time interval (e.g. over a three-month period), and drug products analyzed (e.g. Schedule II opioids) are the 
same. Meaning, the total number (or rates) of individuals who received Schedule II-V opioid prescriptions from 4 or more providers and had them filled 
at 4 or more pharmacies in a 3-month period cannot and should not be compared with the total number of individuals (or rates) who received Schedule 
II-V opioid prescriptions from 4 or more providers and had them filled at 4 or more pharmacies in a 12-month period. 
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MA Prescription Monitoring Program: October 2016 – December 2016 
County                          
(County 
classifications are by 
patient zip code; 
patient state must 
also = MA) 
Census  
Population 
Total 
Schedule II 
Opioid 
Prescriptions 
Total Number 
of Schedule II 
Opioid Solid 
Dosage Units 
Individuals 
Receiving 
Schedule II 
Opioid 
Prescription 
% of Individuals 
Receiving 
Schedule II Opioid 
Prescription 
 (of total 
population) 
Individuals 
with 
Activity of 
Concern 
Rate of 
Individuals 
with Activity of 
Concern  
(per 1,000) 
Barnstable 214,333 25,079 1,447,290 11,477 5.4 10 0.9 
Berkshire 127,828 14,433 808,390 6,460 5.1 6 0.9 
Bristol 556,772 72,346 4,456,020 30,808 5.5 16 0.5 
Dukes 17,299 1,670 104,292 815 4.7 < 5 NR 
Essex 776,043 73,972 4,115,063 34,559 4.5 22 0.6 
Franklin 70,601 9,756 596,312 4,066 5.8 5 1.2 
Hampden 470,690 60,608 3,642,267 26,030 5.5 25 1.0 
Hampshire 161,292 16,917 1,092,669 7,042 4.4 < 5 NR 
Middlesex 1,585,139 105,074 5,774,170 53,112 3.4 47 0.9 
Nantucket 10,925 1,068 45,536 505 4.6 < 5 NR 
Norfolk 696,023 56,772 3,269,906 27,827 4.0 33 1.2 
Plymouth 510,393 54,861 3,290,129 25,609 5.0 23 0.9 
Suffolk 778,121 50,374 3,075,123 24,140 3.1 29 1.2 
Worcester 818,963 85,041 5,466,276 38,382 4.7 41 1.1 
MA 6,794,422 627,971 37,183,442 290,832 4.3 263 0.9 
 
Note 1: Individuals with activity of concern "thresholds" for this report are based ONLY on a 3-month time period; see notes on previous page; CY16-Q4 
Note 2: Counts greater than 0 but less than 5 are not reported.  Rates based on these small values also are not reported (NR). 
Note 3: Rates of individuals with activity of concern are based on the population of individuals who have received one or more Schedule II opioid prescriptions during the 
specified time period. 
Note 4: PMP data are preliminary and subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted by 
pharmacies. This data were extracted on 01/05/2017; Release Date: January 2017. 
Note 5: Beginning in 3rd quarter of 2016, the Department of Veterans Affairs (VA) facilities began submitting data to the MA PMP. 
Note 6: National Center for Health Statistics.  Postcensal estimates of the resident population of the United States for July 1, 2010-July 1, 2015, by year, county, single-year of age 
(0, 1, 2, .., 85 years and over), bridged race, Hispanic origin, and sex (Vintage 2015). 
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Enhancement of Opioid Overdose Surveillance 
MATRIS, the Massachusetts Ambulance Trip Reporting Information System, is a statewide database for 
collecting emergency medical service data from licensed ambulance services.  It was not specifically designed 
to track opioid overdose incidents. DPH is currently working with all Emergency Medical Services (EMS) 
providers to improve the quality and completeness of these data especially with respect to opioid overdose 
incidents.  To more accurately identify ambulance trips that are opioid-related, several pieces of information 
from MATRIS are combined such as: a notation that a trip was listed as a poisoning, that there was an 
administration of naloxone, or that the patient admitted to drug use.  In combination, this information allows 
DPH to more accurately count opioid overdose incidents. Data for Boston came from applying this algorithm 
to events identified by Boston EMS as “Narcotic Related Incidents” (NRI).  Not all services have reported their 
2016 Q1-Q3 data yet so the numbers cited here are underestimates.  Counts will be updated on a quarterly 
basis.   
 
Results 
 
Since 2013, there has been an increasing trend in the percentage of EMS incidents that are considered opioid-
related. In the first three quarters of 2016 EMS services reported an opioid-related incident in 280 of the 351 
MA cities and towns (80%). Overall, there was a 37% increase in the number of opioid-related EMS transport 
incidents compared with the first three quarters of 2015.   
 
In the first three quarters of 2016, the greatest number of suspected opioid overdose incidents was among 
males aged 25-34 (25% of opioid-related incidents).  There is an increasing trend in the quantity of Naloxone 
being dispensed during each opioid-related incident. On average, EMS administered Naloxone 1.4 times per 
opioid-related incident in the first three quarters of 2016. Almost one third of opioid-related incidents 
required more than one dose of Naloxone.  
 
 
All Suspected Opioid Related Incidents: 2016 (Quarter 1) 
  11-14 15-24 25-34 35-44 45-54 55-64 65+ Total 
Male <7 384 1268 767 488 315 136 3359 
Female <7 235 560 313 239 156 107 1614 
Total <7 619 1828 1080 727 471 243 4973 
 
  
Opioid-related EMS Transports  
Massachusetts Residents: 2013-2016 
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All Suspected Opioid Related Incidents: 2016 (Quarter 2) 
  11-14 15-24 25-34 35-44 45-54 55-64 65+ Total 
Male <7 438 1603 904 724 401 178 4250 
Female <7 244 730 424 302 178 141 2024 
Total 7 682 2333 1328 1026 579 319 6274 
 
 
 
All Suspected Opioid Related Incidents: 2016 (Quarter 3) 
  11-14 15-24 25-34 35-44 45-54 55-64 65+ Total 
Male 1 499 1553 948 610 389 186 4187 
Female 0 278 838 441 295 189 118 2159 
Total 1 777 2391 1389 905 578 304 6346 
 
 
 
 
1. Includes all incidents where the patient was 11 years old or older.  
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Technical Notes 
 
This data brief was supported by funds made available from the Centers for Disease Control and Prevention, 
Office for State, Tribal, Local and Territorial Support, under B01OT009024. The findings of this data brief are 
those of the authors and do not necessarily represent the official position of or endorsement by the Centers for 
Disease Control and Prevention. 
 
 
 
 
 
 
 
 
 
